EARLY PSA RESPONSE IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH MCRPC TREATED WITH NEXT-GENERATION ANDROGEN PATHWAY INHIBITORS

被引：1
|
作者：
Fuerea, A. C. [1 ]
Baciarello, G. [1 ]
Massard, C. [2 ]
Sauvin, L. Albiges [3 ]
Gizzi, M. [1 ]
Terrisse, S. A. [4 ]
Di Palma, M. [1 ]
Escudier, B. [5 ]
Fizazi, K. [6 ]
Loriot, Y. [5 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, SITEP, Villejuif, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[4] Inst Canc Res, Dept Med Oncol, Villejuif, France
[5] Inst Cancerol Gustave Roussy, Villejuif, France
[6] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu336.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
796P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    Shagera, Qaid Ahmed
    Karfis, Ioannis
    Kristanto, Paulus
    Spyridon, Sideris
    Diamand, Romain
    Santapau, Albert
    Peltier, Alexandre
    Roumegue, Thierry
    Flamen, Patrick
    Artigas, Carlos
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (12) : 1869 - 1875
  • [42] Early Response in Alkaline Phosphatase as an Independent Predictive Factor for Disease Progression in Castration-Resistant Prostate Cancer Patients with Post-chemotherapy PSA Elevation
    Han, K.
    Kim, K.
    Hong, S.
    UROLOGY, 2012, 80 (03) : S99 - S99
  • [43] Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
    Grech, Christina T.
    Pils, Dietmar
    Aust, Stefanie
    Grimm, Christoph
    Polterauer, Stephan
    Reinthaller, Alexander
    Muellauer, Leonhard
    Reischer, Theresa
    Bekos, Christine
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [44] Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement
    Rigaud, Charlotte
    Abbou, Samuel
    Ducasso, Stephane
    Simonin, Mathieu
    Le Mouel, Lou
    Pereira, Victor
    Gourdon, Stephanie
    Lambilliotte, Anne
    Geoerger, Birgit
    Minard-Colin, Veronique
    Brugieres, Laurence
    HAEMATOLOGICA, 2022, 107 (09) : 2255 - 2260
  • [45] Prognostic Implication of Early Molecular Response at 3 Months in Chronic Myeloid Leukemia Patients: A Comparison of Imatinib and Second Generation Tyrosine Kinase Inhibitors
    Kim, Dong-Wook
    Lee, Sung-Eun
    Choi, Soo Young
    Zang, Dae Young
    Lee, Won-Sik
    Mun, Yeung-Chul
    Do, Young Rok
    Oh, Sukjoong
    BLOOD, 2018, 132
  • [46] Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
    de Herreros, Marta Garcia
    Jimenez, Natalia
    Rodriguez-Carunchio, Leonardo
    Lillo, Eva
    Marin-Aguilera, Mercedes
    Ferrer-Mileo, Laura
    Aversa, Caterina
    Garcia-Esteve, Samuel
    Padrosa, Joan
    Trias, Isabel
    Fernandez-Manas, Laia
    Font, Albert
    Chirivella, Isabel
    Figols, Mariona
    Climent, Miguel Angel
    Prat, Aleix
    Reig, Oscar
    Mellado, Begona
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 70 : 86 - 90
  • [47] Targeted next-generation sequencing (NGS) of 105 cancer-related genes in circulating tumor DNA (ctDNA) from patients with advanced cancers treated with immune checkpoint inhibitors (iCPI).
    Call, S. Greg
    Huang, Helen J.
    Rodon, Jordi
    Karp, Daniel D.
    Tsimberidou, Apostolia M.
    Naing, Aung
    Janku, Filip
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [48] Lymph but Not Blood Vessel Invasion Is Independent Prognostic in Lung Cancer Patients Treated by VATS-Lobectomy and Might Represent a Future Upstaging Factor for Early Stages
    Biesinger, Melanie
    Eicken, Nele
    Varga, Alexander
    Weber, Michael
    Brndiar, Milos
    Erd, Georg
    Errhalt, Peter
    Hackner, Klaus
    Hintermair, Sarah
    Petter-Puchner, Alexander
    Scheed, Axel
    Stubenberger, Elisabeth
    Ghanim, Bahil
    CANCERS, 2022, 14 (08)
  • [49] Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
    Smith, Alexander E.
    Mohamedali, Azim M.
    Kulasekararaj, Austin
    Lim, ZiYi
    Gaeken, Joop
    Lea, Nicholas C.
    Przychodzen, Bartlomiej
    Mian, Syed A.
    Nasser, Erick E.
    Shooter, Claire
    Westwood, Nigel B.
    Strupp, Corinna
    Gattermann, Norbert
    Maciejewski, Jaroslaw P.
    Germing, Ulrich
    Mufti, Ghulam J.
    BLOOD, 2010, 116 (19) : 3923 - 3932
  • [50] Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients
    Kobayashi, Hiroki
    Shiota, Masaki
    Sato, Nobuaki
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Monji, Keisuke
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Shiga, Ken-ichiro
    Yokomizo, Akira
    Eto, Masatoshi
    ANTI-CANCER DRUGS, 2022, 33 (01) : E541 - E547
12345